Apelin is expressed throughout the human kidney, is elevated in chronic kidney disease & associates independently

Duuamene Nyimanu1, Fiona A Chapman2,3, Peter J Gallacher2

  • 1Division of Experimental Medicine and Immunotherapeutics, University of Cambridge, Cambridge, UK.

Insights

Plasma apelin is elevated in chronic kidney disease (CKD) and may indicate a higher risk of kidney function decline. The apelin system is present in healthy kidneys, warranting further research into apelin agonism as a CKD therapy.

Area of Science:

  • Nephrology
  • Cardiovascular Medicine
  • Endocrinology

Background:

  • Cardiovascular disease (CVD) is a major complication of chronic kidney disease (CKD).
  • The apelin system presents a potential therapeutic target for CVD, but its role in CKD remains under-explored.
  • Limited data exist on the expression and function of the apelin system in the context of CKD.

Purpose of the Study:

  • To investigate the expression of the apelin system in healthy human kidneys.
  • To examine the levels of apelin and Elabela/Toddler (ELA) in patients with CKD.
  • To explore the association between apelin, ELA, and cardiovascular health in CKD patients.

Main Methods:

  • Autoradiography, immunohistochemistry, and ELISA were used to assess apelin system expression in kidney tissue.
  • Plasma levels of apelin and ELA were measured in 128 CKD patients and 27 healthy controls.
  • Cardiovascular parameters including blood pressure, arterial stiffness, and endothelial function were assessed over a 5-year follow-up period.

Main Results:

  • The apelin system is expressed throughout the nephron in healthy human kidneys.
  • Plasma apelin concentrations were significantly higher in women than men and increased with declining glomerular filtration rate and rising albuminuria in CKD patients.
  • Elevated plasma apelin and ELA were associated with vascular dysfunction, and plasma apelin independently predicted a 50% decline in glomerular filtration rate over 5 years.

Conclusions:

  • This study demonstrates the expression of the apelin system in healthy human kidneys.
  • Elevated plasma apelin levels in CKD patients may serve as a potential biomarker for the risk of kidney function decline.
  • Further clinical investigations into the therapeutic potential of apelin agonism for CKD are warranted.
Abstract

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
65
Nephrons01:10

Nephrons

The kidneys are intricate organs with millions of working units known as nephrons. Each nephron features two major structures: the renal corpuscle, which facilitates blood plasma filtration, and the renal tubule, which handles the glomerular filtrate. Blood supply is directly linked to the nephrons. The renal corpuscle consists of the glomerulus, a capillary network, and the Bowman's capsule, a double-walled epithelial structure that encases the glomerulus. The filtering of blood plasma...
3.4K
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
81
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
77
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
69
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
56